EA202191707A1 - MODULATING T-CELLS MULTIMERIC POLYPEPTIDES AND METHODS OF THEIR APPLICATION - Google Patents

MODULATING T-CELLS MULTIMERIC POLYPEPTIDES AND METHODS OF THEIR APPLICATION

Info

Publication number
EA202191707A1
EA202191707A1 EA202191707A EA202191707A EA202191707A1 EA 202191707 A1 EA202191707 A1 EA 202191707A1 EA 202191707 A EA202191707 A EA 202191707A EA 202191707 A EA202191707 A EA 202191707A EA 202191707 A1 EA202191707 A1 EA 202191707A1
Authority
EA
Eurasian Patent Office
Prior art keywords
modulating
cells
methods
application
multimeric polypeptides
Prior art date
Application number
EA202191707A
Other languages
Russian (ru)
Inventor
Рональд Д. Сайдел III
Родольфо Дж. Чапарро
Original Assignee
Кью Биофарма, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кью Биофарма, Инк. filed Critical Кью Биофарма, Инк.
Priority claimed from PCT/US2019/067575 external-priority patent/WO2020132297A1/en
Publication of EA202191707A1 publication Critical patent/EA202191707A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

В данном изобретении предлагаются модулирующие Т-клетки мультимерные полипептиды, которые содержат иммуномодулирующий полипептид и которые содержат эпитоп-презентирующий пептид опухоли Вильмса. Модулирующий Т-клетки мультимерный полипептид пригоден для модуляции активности Т-клеток, а также для модуляции иммунного ответа у индивидуума.The present invention provides multimeric T-cell modulating polypeptides that contain an immunomodulatory polypeptide and that contain a Wilms tumor epitope-presenting peptide. The T cell modulating multimeric polypeptide is useful for modulating T cell activity as well as for modulating the immune response in an individual.

EA202191707A 2019-03-06 2019-12-19 MODULATING T-CELLS MULTIMERIC POLYPEPTIDES AND METHODS OF THEIR APPLICATION EA202191707A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962814684P 2019-03-06 2019-03-06
PCT/US2019/067575 WO2020132297A1 (en) 2018-12-19 2019-12-19 Multimeric t-cell modulatory polypeptides and methods of use thereof

Publications (1)

Publication Number Publication Date
EA202191707A1 true EA202191707A1 (en) 2022-03-04

Family

ID=81077512

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191707A EA202191707A1 (en) 2019-03-06 2019-12-19 MODULATING T-CELLS MULTIMERIC POLYPEPTIDES AND METHODS OF THEIR APPLICATION

Country Status (1)

Country Link
EA (1) EA202191707A1 (en)

Similar Documents

Publication Publication Date Title
EA202090471A1 (en) MODULATING T-CELLS MULTI-DIMENSIONAL POLYPEPTIDES AND WAYS OF THEIR APPLICATION
MX2021014476A (en) Multimeric t-cell modulatory polypeptides and methods of use thereof.
MX2021007287A (en) Multimeric t-cell modulatory polypeptides and methods of use thereof.
EA202190906A1 (en) RECOMBINANT PREPARATION OF COLLAGEN PEPTIDES AND THEIR APPLICATION
CL2020000039A1 (en) Fusion proteins, recombinant bacteria and methods of using recombinant bacteria. (divisional request 201700647)
MX2023013883A (en) T-cell modulatory multimeric polypeptides and methods of use thereof.
MX2021007479A (en) Multimeric t-cell modulatory polypeptides and methods of use thereof.
PH12020551391A1 (en) Antibodies against signal-regulatory protein alpha and methods of use
EA201891589A1 (en) CONDITIONALLY ACTIVE HETERODIMERIC POLYPEPTIDES AND METHODS OF THEIR APPLICATION
MX2022003367A (en) T-cell modulatory polypeptides and methods of use thereof.
AU2017266905A1 (en) Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and methods of use thereof
MX2022013208A (en) Multimeric t-cell modulatory polypeptides and methods of use thereof.
MX2019004327A (en) Bispecific heterodimeric fusion proteins containing il-15/il-15ralpha fc-fusion proteins and pd-1 antibody fragments.
PE20170503A1 (en) INTERLEUKIN 2 / INTERLEUKIN-2 ALPHA RECEPTOR FUSION PROTEINS AND METHODS OF USE
MX2017010553A (en) Retroviral and lentiviral vectors.
EA201992536A1 (en) TCR AND PEPTIDES
EA202090757A1 (en) T-CELL RECEPTORS RECOGNIZING THE MUTANT p53
MX2021000263A (en) SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF.
PH12020552222A1 (en) Immunodominant proteins and fragments in multiple sclerosis
EA202191707A1 (en) MODULATING T-CELLS MULTIMERIC POLYPEPTIDES AND METHODS OF THEIR APPLICATION
EA202192781A1 (en) DEVICE FOR GRINDING BIOLOGICAL MATERIAL AND CORRESPONDING METHOD FOR GRINDING AND PREPARING CELL PREPARATIONS
EA202192937A1 (en) MODULATING T-CELLS MULTIMERIC POLYPEPTIDES AND METHODS OF THEIR APPLICATION
EA202092065A1 (en) EXPRESSION OF PNEUMOCOCCAL SURFACE PROTEIN A (PspA)
MX2022000081A (en) Anti-new york esophageal squamous cell carcinoma 1 (ny-eso-1) antigen-binding proteins and methods of use thereof.
EA202191705A1 (en) MODULATING T-CELLS MULTIMERIC POLYPEPTIDES AND METHODS OF THEIR APPLICATION